Gleevec® Side Effects Lawsuit
Phillips Law Group is no longer accepting Gleevec cases and therefore, the information on this page is provided for informational purposes only. After the initial report in July 2006 linking Gleevec to cardiac and other side effects, in October 2006 the manufacturer, Novartis, informed healthcare providers of the potential for severe congestive heart failure and left ventricular dysfunction and included additional information on the product’s package insert. As with any healthcare issue, you should discuss any questions about Gleevec with your physician.
Gleevec is used to treat two types of cancer: chronic myelogenous leukemia (CML) and a rare type of stomach cancer known as gastrointestinal stromal tumors (GIST). While Gleevac was hailed as a revolutionary treatment when it hit the market in 2001, its recently discovered side effects are enough to cause serious personal injury or even death. Heart failure generally kills half of patients within five years.
Gleevec Side Effects
A recent study, published in the New England Journal of Medicine, publicized the disturbing side effects heart failure and problems in remodeling bones some Gleevec patients have experienced.
The study recommended that all patients taking Gleevec be closely monitored for these dangerous side effects. Those who have taken the drug before the study was publicized in July 2006, however, might not have had the benefit of this monitoring and may have suffered from dangerous side effects, including heart failure. If you or a loved one has taken Gleevec and have suffered bone- or heart-related side effects, you may be able to pursue a claim against the manufacturer, Swiss drugmaker Novartis Pharmaceuticals.